Pep-Therapy And Conectus Alsace Join Forces To Develop A New Targeted Therapeutic Peptide For Type Ii Diabetes

Pep-Therapy And Conectus Alsace Join Forces To Develop A New Targeted Therapeutic Peptide For Type Ii Diabetes